We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$1.17B
Cap. Flow
+$816M
Cap. Flow %
16.26%
Top 10 Hldgs %
31.54%
Holding
2,471
New
743
Increased
409
Reduced
522
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 10.76%
2 Financials 10.52%
3 Healthcare 8.02%
4 Industrials 7.74%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPUS
1576
Hyperscale Data Inc
GPUS
$55.4M
0
VAPO
1577
PUT
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$115K ﹤0.01%
+500
New +$144K
EXAS
1578
DELISTED
Exact Sciences
EXAS
$111K ﹤0.01%
1,085
-27,143
-96% -$2.34M
HTT
1579
High Templar Tech Ltd
HTT
$394M
$111K ﹤0.01%
+89,864
New +$152K
CAMP
1580
DELISTED
CalAmp Corp.
CAMP
$110K ﹤0.01%
662
-741
-53% -$139K
DESP
1581
DELISTED
Despegar.com
DESP
$108K ﹤0.01%
16,961
-24,239
-59% -$193K
PTEN icon
1582
Patterson-UTI
PTEN
$4.19B
$108K ﹤0.01%
+37,823
New +$139K
SBBP
1583
DELISTED
Strongbridge Biopharma plc.
SBBP
$107K ﹤0.01%
+50,782
New +$171K
CYCN icon
1584
Cyclerion Therapeutics
CYCN
$16.8M
$105K ﹤0.01%
+867
New +$99.1K
CIO
1585
DELISTED
City Office REIT
CIO
$103K ﹤0.01%
+13,707
New +$119K
MRC
1586
DELISTED
MRC Global
MRC
$103K ﹤0.01%
24,150
+14,094
+140% +$81K
PSEC icon
1587
Prospect Capital
PSEC
$1.15B
$103K ﹤0.01%
+20,530
New +$103K
CCJ icon
1588
Cameco
CCJ
$42.4B
$102K ﹤0.01%
+10,090
New +$109K
XERS icon
1589
Xeris Biopharma Holdings
XERS
$1.46B
$100K ﹤0.01%
16,867
-15,715
-48% -$62.8K
CAL icon
1590
Caleres
CAL
$486M
$99K ﹤0.01%
10,315
-17,199
-63% -$138K
MUX icon
1591
McEwen Inc
MUX
$1.18B
$99K ﹤0.01%
9,302
+7,211
+345% +$87.4K
WSR
1592
DELISTED
Whitestone REIT
WSR
$99K ﹤0.01%
+16,425
New +$107K
NGD
1593
DELISTED
New Gold Inc
NGD
$98K ﹤0.01%
+57,363
New +$92.2K
DHC
1594
Diversified Healthcare Trust
DHC
$2.04B
$97K ﹤0.01%
27,445
-15,963
-37% -$62.3K
RIGL icon
1595
Rigel Pharmaceuticals
RIGL
$778M
$96K ﹤0.01%
3,991
+1,681
+73% +$41.3K
LPL icon
1596
LG Display
LPL
$3.36B
$95K ﹤0.01%
+14,499
New +$85.4K
CSPR
1597
DELISTED
Casper Sleep Inc.
CSPR
$95K ﹤0.01%
+13,202
New +$110K
LADR
1598
Ladder Capital
LADR
$1.22B
$94K ﹤0.01%
+13,194
New +$99.2K
EEM icon
1599
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$93K ﹤0.01%
+2,100
New +$92.1K
KALA icon
1600
KALA BIO
KALA
$14.6M
$93K ﹤0.01%
5
-3
-38% -$69K

Similar funds

ExodusPoint Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, ExodusPoint Capital Management held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ExodusPoint Capital Management deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.

  • ExodusPoint Capital Management's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
  • ExodusPoint Capital Management added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
  • ExodusPoint Capital Management's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
  • ExodusPoint Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
  • ExodusPoint Capital Management's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
  • ExodusPoint Capital Management opened 743 new positions and closed 789 in Q3 2020.
  • ExodusPoint Capital Management's portfolio value rose 30% quarter-over-quarter to $5.02B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.